Fang Yuan, Jeffery Alvin D, Patrick Stephen W, Young Jessica, Raffi Edwin, Harder Gabrielle M, Osmundson Sarah, Phillippi Julia C, Leech Ashley A
Department of Psychology, University of Notre Dame, Notre Dame, IN (YF); School of Nursing, Vanderbilt University, Nashville, TN (ADJ, JCP); Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN (ADJ); Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN (GMH, AAL); Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA (SWP); Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, GA (SWP); Health Services Research Center, Emory University School of Medicine, Emory University, Atlanta, GA (SWP); Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN (JY, SO); and Massachusetts General Hospital and Harvard Medical School, Boston MA (ER).
J Addict Med. 2025;19(4):403-411. doi: 10.1097/ADM.0000000000001434. Epub 2024 Dec 31.
The aim of the study was to examine the relationship between opioid use disorder (OUD)-related service trajectories during pregnancy and postpartum emergency department (ED) and hospitalizations.
We used the Merative MarketScan Commercial Claims and Encounters Database (2013-2021) to identify a cohort of pregnant individuals with OUD. We used group-based multitrajectory modeling to identify opioid-related treatment and service trajectories during pregnancy and examined their association with postpartum ED and hospital utilization.
Seven opioid-related treatment and service trajectories were identified in our cohort of 2,531 pregnant individuals with OUD. Compared to individuals initiating medications for OUD (MOUD) halfway through pregnancy but maintaining high adherence without ancillary services, those receiving only services throughout pregnancy had a higher risk of postpartum ED visits ( HR ED = 1.34). This latter group also faced significantly higher risks of postpartum hospitalizations, compared to adherent MOUD use (proportion of days covered ≥80%) alone, both throughout or in the latter half of pregnancy ( HR HOS = 1.93; HR HOS = 1.60), and patients without MOUD or services ( HR HOS = 1.43). Individuals initiating MOUD late in pregnancy with poor adherence and infrequent service use faced significantly higher risks of postdelivery hospitalization compared to consistent MOUD users throughout pregnancy ( HR HOS = 2.33), or in the latter half, with or without services ( HR HOS = 2.02; HR HOS = 1.93), and those not receiving MOUD or services ( HR HOS = 1.73).
Adherent MOUD use either throughout pregnancy or the latter half of pregnancy, irrespective of other service use, was associated with better postpartum outcomes defined by fewer ED visits and hospitalizations.
本研究旨在探讨孕期阿片类物质使用障碍(OUD)相关服务轨迹与产后急诊科(ED)就诊及住院情况之间的关系。
我们使用默克多市场扫描商业索赔和会诊数据库(2013 - 2021年)来确定一组患有OUD的孕妇队列。我们使用基于组的多轨迹模型来识别孕期与阿片类物质相关的治疗和服务轨迹,并研究它们与产后ED就诊及住院利用情况的关联。
在我们的2531名患有OUD的孕妇队列中,识别出了七种与阿片类物质相关的治疗和服务轨迹。与在孕期中途开始使用阿片类物质使用障碍药物(MOUD)但保持高依从性且无需辅助服务的个体相比,那些在整个孕期仅接受服务的个体产后ED就诊风险更高(ED风险比 = 1.34)。与仅使用MOUD(覆盖天数比例≥80%)相比(无论在孕期全程还是后半段),这后一组在产后住院方面也面临显著更高的风险,同时与未使用MOUD或接受服务的患者相比也是如此(住院风险比 = 1.93;住院风险比 = 1.60;住院风险比 = 1.43)。与整个孕期持续使用MOUD的个体相比,在孕期晚期开始使用MOUD且依从性差、很少接受服务的个体产后住院风险显著更高(住院风险比 = 2.33),或者在孕期后半段,无论有无服务(住院风险比 = 2.02;住院风险比 = 1.93),以及未接受MOUD或服务的个体(住院风险比 = 1.73)。
在整个孕期或孕期后半段持续使用MOUD,无论是否使用其他服务,都与更好的产后结局相关,即ED就诊和住院次数减少。